Vertex VERX 深 滬
已收盤 07-10 16:00:00 美东时间
12.38
-0.420
-3.28%
華盛通- 最 高13.235
- 今 開13.21
- 成交量 123.92万股
- 最 低 12.35
- 昨 收 12.80
- 總市值 20.03亿
- 52周最高 36.75
- 市盈率 靜 278.83
- 換手率 0.77%
- 52周最低 10.21
- 委 比 -41.71%
- 總股本 1.62亿
- 歷史最高 60.71
- 量 比 0.90
- 振 幅 6.91%
- 歷史最低 9.44
- 每 手 1
- 風險率 6.73%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Crinetics Pharmaceuticals Announces Merger Agreement With Vertex
Crinetics Pharmaceuticals ( ($CRNX) ) has provided an announcement. On July 6, ...
今天 04:34
福泰制药(VRTX)股票7月8日盘中下跌3.09%：投资者必看的核心信息
• Vertex Pharmaceuticals已同意以100亿美元现金收购Crinetics Pharmaceuticals。 • 此次收购溢价超过Crinetics股价的100%。 • 在估值创历史新高期间，高管们根据预先安排的交易计划出售了公司股票。
07-08 18:15
Vertex Pharmaceuticals Inc Stock (VRTX) Moved Down by 3.09% on Jul 8: Key Drivers Unveiled
• Vertex Pharmaceuticals agreed to acquire Crinetics Pharmaceuticals for ten billion dollars cash. • The acquisition includes a premium exceeding one hundred percent of Crinetics' share price. • Executives sold company shares under pre-arranged trading plans during record-high valuations.
07-08 18:15
NewcelX Appoints World-Renowned Diabetes Cure-Focused Pioneer, Dr. Camillo Ricordi, to Scientific Advisory Board
NewcelX Ltd. has appointed Camillo Ricordi, M.D., F.N.A.I., a leading authority in diabetes research and cellular transplantation, to its Scientific Advisory Board. Dr. Ricordi's expertise will support the advancement of NewcelX's Type 1 Diabetes program and strategic collaboration with Eledon Pharmaceuticals. This appointment follows NewcelX's successful FDA Type B Pre-IND meeting for NCEL-101, providing a clear path toward clinical trials. Dr. ...
07-08 13:15
百亿美金并购新狂潮背后
原标题：百亿美金并购新狂潮背后 又一笔百亿美元级并购诞生。 7月6日，Vertex宣布以每股85美元、总价约100亿美元的全现金交易，正式将专注于内分泌罕见病...
07-08 10:19
Vertex斥资100亿美元收购Crinetics，后者股价盘前暴涨近99%
生物制药公司Crinetics股价周二盘前交易中几乎翻倍，此前生物技术公司Vertex宣布了一项100亿美元的收购计划。 Vertex同意以每股85美元...
07-07 20:10
FACTBOX-Major deals involving US drugmakers and biotechs over the past decade
FACTBOX-Major deals involving US drugmakers and biotechs over the past decade Adds details of Vertex deal in paragraphs 1 and table July 7 (Reuters) - Vertex Pharmaceuticals VRTX.O has agreed to buy Crinetics Pharmaceuticals CRNX.O for about $10 billion , expanding its reach beyond blood disorders a
07-07 18:08
Vertex to Acquire Crinetics in $10 Billion Merger
An announcement from Crinetics Pharmaceuticals ( ($CRNX) ) is now available. On...
07-07 05:50
Crinetics Pharmaceuticals Stock Doubles After The Close: Here's Why
Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) shares are trading higher in Monday’s after-hours session after the company announced it will be acquired by Vertex Pharmaceuticals Inc (NASDAQ:VRTX). Crinetics Pharmaceuticals stock is soaring. What’s the outlook for CRNX shares? Vertex To Acquire Crineti...
07-07 04:30
Vertex Pharmaceuticals Agrees To Acquire Crinetics Pharmaceuticals For $85/Share In Cash
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) and Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for endocrine diseases, today announced that the companies have entered into a defini...
07-07 04:05
